Skip to main content
. 2021 Apr 22;13(5):600. doi: 10.3390/pharmaceutics13050600

Figure 3.

Figure 3

The cellular uptake in MDA-MB-231, 4T1, and MCF-7 cells after treatment with Cou-6-Sol, Cou-6 labeled NLC, and modified Cou-6 labeled NLC at different incubation time intervals (4 h, 8 h). * p < 0.05; ** p < 0.01; *** p < 0.001; n.s., not significant. Results are expressed as mean ± SD, n = 3.